series-a
Stage
2008
Founded
2
Investors
About
Herantis Pharma is a clinical-stage biotechnology company developing protein- and peptide-based therapeutics, notably a CDNF (cerebral dopamine neurotrophic factor) program for Parkinson’s disease and other neurodegenerative and ophthalmic indications.
Explore Herantis Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.